{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:51:28Z","timestamp":1648867888334},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00059-016-4474-9","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T18:29:59Z","timestamp":1472840999000},"page":"537-560","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nationale Versorgungsleitlinie (NVL) Chronische KHK"],"prefix":"10.1007","volume":"41","author":[{"given":"K.","family":"Werdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"4474_CR1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht310.P4876","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F et\u00a0al (2013) ESC guidelines on the management of stable coronary artery disease: The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949\u20133003","journal-title":"Eur Heart J"},{"key":"4474_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12181-015-0652-x","volume":"9","author":"U Sechtem","year":"2015","unstructured":"Sechtem U, Achenbach S, Gitt AK, Marx N et\u00a0al (2015) Kommentar zu den 2013 Leitlinien der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie (ESC) zum Management der stabilen koronaren Herzkrankheit (KHK). Kardiologe 9:159\u2013164","journal-title":"Kardiologe"},{"key":"4474_CR3","volume-title":"ESC Pocket Guidelines Management der stabilen koronaren Herzkrankheit (KHK)","author":"U Sechtem","year":"2013","unstructured":"Sechtem U, Achenbach S, Gitt AK, Deutsche Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung (2013) ESC Pocket Guidelines Management der stabilen koronaren Herzkrankheit (KHK)"},{"key":"4474_CR4","doi-asserted-by":"publisher","DOI":"10.610\/AZQ\/000267.","volume-title":"Nationale VersorgungsLeitlinie Chronische KHK \u2013 Langfassung","author":"Bundes\u00e4rztekammer (B\u00c4K)","year":"2016","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2016) Nationale VersorgungsLeitlinie Chronische KHK \u2013 Langfassung, 4.\u00a0Aufl. doi: 10.610\/AZQ\/000267.","edition":"4"},{"issue":"7308","key":"4474_CR5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","volume":"323","author":"R Harbour","year":"2001","unstructured":"Harbour R, Miller J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323(7308):334\u2013336","journal-title":"BMJ"},{"issue":"Suppl III","key":"4474_CR6","first-page":"3","volume":"96","author":"Europarat","year":"2001","unstructured":"Europarat, Verbindung der Schweizer \u00c4rztinnen und \u00c4rzte, \u00c4rztliche Zentralstelle Qualit\u00e4tssicherung (\u00c4ZQ), Europarat, Verbindung der Schweizer \u00c4rztinnen und \u00c4rzte (2001) Entwicklung einer Methodik f\u00fcr die Ausarbeitung von Leitlinien f\u00fcr optimale medizinische Praxis. Empfehlung Rec 13 des Europarates am 10. Oktober 2001 und Erl\u00e4uterndes Memorandum. Deutschsprachige Ausgabe. Z Arztl Fortbild Qualitatssich 96(Suppl III):3\u201360","journal-title":"Z Arztl Fortbild Qualitatssich"},{"issue":"7650","key":"4474_CR7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et\u00a0al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","journal-title":"BMJ"},{"issue":"5\u20136","key":"4474_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00103-013-1666-9","volume":"56","author":"A Gosswald","year":"2013","unstructured":"Gosswald A, Schienkiewitz A, Nowossadeck E et\u00a0al (2013) Pr\u00e4valenz von Herzinfarkt und koronarer Herzkrankheit bei Erwachsenen im Alter von 40 bis 79\u00a0Jahren in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5\u20136):650\u2013655","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"4474_CR9","volume-title":"Deutscher Herzbericht 2015","author":"Deutsche Herzstiftung","year":"2015","unstructured":"Deutsche Herzstiftung (2015) Deutscher Herzbericht 2015"},{"key":"4474_CR10","volume-title":"Statistik der h\u00e4ufigsten Todesursachen 2003\u20132013","author":"Gesundheitsberichterstattung des Bundes (GBE)","year":"2015","unstructured":"Gesundheitsberichterstattung des Bundes (GBE) (2015) Statistik der h\u00e4ufigsten Todesursachen 2003\u20132013. http:\/ www.gbe-bund.de . Zugegriffen: 24. M\u00e4rz 2015"},{"issue":"7536","key":"4474_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.38695.605440.AE","volume":"332","author":"CA Daly","year":"2006","unstructured":"Daly CA, de Stavola B, Sendon JL et\u00a0al (2006) Predicting prognosis in stable angina \u2013 results from the Euro heart survey of stable angina: prospective observational study. BMJ 332(7536):262\u2013267","journal-title":"BMJ"},{"issue":"12","key":"4474_CR12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1503\/cmaj.100212","volume":"182","author":"S Bosner","year":"2010","unstructured":"Bosner S, Haasenritter J, Becker A et\u00a0al (2010) Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule. CMAJ 182(12):1295\u20131300","journal-title":"CMAJ"},{"issue":"599","key":"4474_CR13","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3399\/bjgp12X649106","volume":"62","author":"J Haasenritter","year":"2012","unstructured":"Haasenritter J, Bosner S, Vaucher O et\u00a0al (2012) Ruling out coronary heart disease in primary care: external validation of a clinical prediction rule. Br J Gen Pract 62(599):e415\u2013e421","journal-title":"Br J Gen Pract"},{"key":"4474_CR14","first-page":"Doc02","volume":"8","author":"V Gorenoi","year":"2012","unstructured":"Gorenoi V, Schonermark MP, Hagen A (2012) CT coronary angiography vs. invasive coronary angiography in CHD. GMS Health Technol Assess 8:Doc02","journal-title":"GMS Health Technol Assess"},{"issue":"6","key":"4474_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-154-6-201103150-00007","volume":"154","author":"MW Ballmoos Von","year":"2011","unstructured":"Von Ballmoos MW, Haring B, Juillerat P et al (2011) Meta-analysis: diagnostic performance of low-radiation-dose coronary computed tomography angiography. Ann Intern Med 154(6):413\u2013420","journal-title":"Ann Intern Med"},{"issue":"1","key":"4474_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.80.1.87","volume":"80","author":"R Gianrossi","year":"1989","unstructured":"Gianrossi R, Detrano R, Mulvihill D et al (1989) Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 80(1):87\u201398","journal-title":"Circulation"},{"issue":"8","key":"4474_CR17","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0735-1097(02)02164-2","volume":"40","author":"RJ Gibbons","year":"2002","unstructured":"Gibbons RJ, Balady GJ, Bricker JT et\u00a0al (2002) ACC\/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J\u00a0Am Coll Cardiol 40(8):1531\u20131540","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4474_CR18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0002-9149(98)00963-1","volume":"83","author":"Y Kwok","year":"1999","unstructured":"Kwok Y, Kim C, Grady D et al (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83(5):660\u2013666","journal-title":"Am J Cardiol"},{"issue":"2","key":"4474_CR19","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.3310\/hta8020","volume":"8","author":"J Mant","year":"2004","unstructured":"Mant J, McManus RJ, Oakes RA et\u00a0al (2004) Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. Health Technol Assess 8(2):iii2\u2013iii158","journal-title":"Health Technol Assess"},{"key":"4474_CR20","first-page":"Doc07","volume":"7","author":"V Gorenoi","year":"2011","unstructured":"Gorenoi V, Sch\u00f6nemark MP, Hagen A (2011) Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris. GMS Health Technol Assess 7:Doc07","journal-title":"GMS Health Technol Assess"},{"issue":"12","key":"4474_CR21","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIR.0000000000000019","volume":"129","author":"JH Lichtman","year":"2014","unstructured":"Lichtman JH, Froelicher ES, Blumenthal JA et\u00a0al (2014) Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129(12):1350\u20131369","journal-title":"Circulation"},{"issue":"23","key":"4474_CR22","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","volume":"27","author":"A Nicholson","year":"2006","unstructured":"Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27(23):2763\u20132774","journal-title":"Eur Heart J"},{"issue":"1","key":"4474_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12181-012-0478-8","volume":"7","author":"KH Ladwig","year":"2013","unstructured":"Ladwig KH, Lederbogen F, Albus C et\u00a0al (2013) Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie. Update 2013. Kardiologe 7(1):7\u201327","journal-title":"Kardiologe"},{"issue":"3","key":"4474_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQoL Group","year":"1990","unstructured":"The EuroQoL Group (1990) EuroQoL \u2013 a new facility for the measurement of health-related quality of life. Health Policy (New York) 16(3):199\u2013208","journal-title":"Health Policy (New York)"},{"issue":"38","key":"4474_CR25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","volume":"34","author":"R Chaudhury","year":"2013","unstructured":"Chaudhury R, Khan H, Heydon E et al (2013) Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 34(38):2940\u20132948","journal-title":"Eur Heart J"},{"issue":"9","key":"4474_CR26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS (2012) Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med 125(9):882\u2013887","journal-title":"Am J Med"},{"key":"4474_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106","author":"MF Piepoli","year":"2016","unstructured":"Piepoli MF, Hoes AW, Agewall S et\u00a0al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J. doi: 10.1093\/eurheartj\/ehw106","journal-title":"Eur Heart J"},{"key":"4474_CR28","unstructured":"Gohlke H, Gielen S, K\u00f6nig W, Schuler G et al (2012) Pr\u00e4vention von Herz- Kreislauf-Erkrankungen Update 2012 (ESC POCKET GUIDELINES). Deutsche Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung,"},{"key":"4474_CR29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12181-013-0507-2","volume":"7","author":"GC Schuler","year":"2013","unstructured":"Schuler GC, Koenig W, Adams V, Gohlke H (2013) Kommentar zu den neuen Leitlinien (2012) der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie zur kardiovaskul\u00e4ren Pr\u00e4vention. Kardiologe 7:251\u2013260","journal-title":"Kardiologe"},{"issue":"13","key":"4474_CR30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2009.10.056","volume":"55","author":"KJ Mukamal","year":"2010","unstructured":"Mukamal KJ, Chen CM, Rao SR, Breslow RA (2010) Alcohol consumption and cardiovascular mortality among U.S adults, 1987 to 2002. J\u00a0Am Coll Cardiol 55(13):1328\u20131335","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"4474_CR31","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, IMPROVE-IT Investigators et al (2015) Ezetimibe added to Statin therapy after acute coronary syndromes. N Engl J Med 372(25):2387\u20132397","journal-title":"N Engl J Med"},{"issue":"25","key":"4474_CR32","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMe1507041","volume":"372","author":"JA Jarcho","year":"2015","unstructured":"Jarcho JA, Keaney JF Jr (2015) Proof that lower is better \u2013 LDL cholesterol and IMPROVE-IT. N Engl J Med 372(25):2448\u20132450","journal-title":"N Engl J Med"},{"issue":"6","key":"4474_CR33","first-page":"48","volume":"50","author":"Arzneimittelbrief","year":"2016","unstructured":"Arzneimittelbrief (2016) Beschl\u00fcsse des Gemeinsamen Bundesausschusses (G- BA) zur fr\u00fchen Nutzenbewertung neuer Arzneimittel \u2013 Alirocumab. Arzneimittelbrief 50(6):48","journal-title":"Arzneimittelbrief"},{"issue":"16","key":"4474_CR34","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JG Robinson","year":"2015","unstructured":"Robinson JG, Farnier M, Krempf M, ODYSSEY LONG TERM Investigators et\u00a0al (2015) Efficacy and safety of Alirocumab in reducing lipids and cardiovascular events. N Engl J Med 372(16):1489\u20131499","journal-title":"N Engl J Med"},{"issue":"16","key":"4474_CR35","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MC Sabatine","year":"2015","unstructured":"Sabatine MC, Giugliano RP, Wiviott SD, Open-Label Study of Long- Term Evaluation against LDL Cholesterol (OSLER) Investigators et al (2015) Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events. N Engl J Med 372(16):1500\u20131509","journal-title":"N Engl J Med"},{"issue":"16","key":"4474_CR36","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe1502192","volume":"372","author":"NJ Stone","year":"2015","unstructured":"Stone NJ, Lloyd-Jones DM (2015) Lowering LDL cholesterol is good, but how and in whom? N Engl J Med 372(16):1564\u20131565","journal-title":"N Engl J Med"},{"key":"4474_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157340312801215764","volume":"8","author":"A Kezerashvili","year":"2012","unstructured":"Kezerashvili A, Marzo K, De Leon J (2012) Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it \u201eok\u201c to discontinue? Curr Cardiol Rev 8:77\u201384","journal-title":"Curr Cardiol Rev"},{"issue":"16","key":"4474_CR38","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","volume":"26","author":"Jochmann","year":"2005","unstructured":"Jochmann, Stangls K, Garbe E et al (2005) Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26(16):1585\u20131595","journal-title":"Eur Heart J"},{"issue":"1","key":"4474_CR39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/oxfordjournals.eurheartj.a060043","volume":"13","author":"G Olsson","year":"1992","unstructured":"Olsson G, Wikstrand J, Warnold I et al (1992) Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 13(1):28\u201332","journal-title":"Eur Heart J"},{"issue":"7200","key":"4474_CR40","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P et\u00a0al (1999) Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318(7200):1730\u20131737","journal-title":"BMJ"},{"key":"4474_CR41","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665","journal-title":"BMJ"},{"issue":"3","key":"4474_CR42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","volume":"64","author":"C Andersson","year":"2014","unstructured":"Andersson C, Shilane D, Go AS et al (2014) Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease. J Am Coll Cardiol 64(3):247\u2013252","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"4474_CR43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","volume":"308","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Steg PG, Deedwania P, REACH Registry Investigators et al (2012) \u03b2\u2011blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 308(13):1340\u20131349","journal-title":"JAMA"},{"issue":"3","key":"4474_CR44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2014.04.043","volume":"64","author":"PG Steg","year":"2014","unstructured":"Steg PG, De Silva R (2014) Beta-blockers in asymptomatic coronary artery disease \u2013 no benefit or no evidence? J Am Coll Cardiol 64(3):253\u2013255","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"4474_CR45","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/01.CIR.0000012546.20194.33","volume":"105","author":"JK Ghali","year":"2002","unstructured":"Ghali JK, Pina IL, Gottlieb SS et al (2002) Metoprolol CR\/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105(13):1585\u20131591","journal-title":"Circulation"},{"issue":"8","key":"4474_CR46","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4065\/84.8.718","volume":"84","author":"M Klapholz","year":"2009","unstructured":"Klapholz M (2009) \u03b2\u2011blocker use for the stags of heart failure. Mayo Clin Proc 84(8):718\u2013729","journal-title":"Mayo Clin Proc"},{"key":"4474_CR47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1388-9842(01)00144-1","volume":"3","author":"MC Shibata","year":"2001","unstructured":"Shibata MC, Flather MD, Wang D (2001) Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 3:351\u2013357","journal-title":"Eur J Heart Fail"},{"key":"4474_CR48","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"D Kotecha","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H, Beta-Blocker in Heart Failure Collaborative Group et al (2014) Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384:2235\u20132243","journal-title":"Lancet"},{"issue":"13","key":"4474_CR49","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jacc.2015.07.047","volume":"66","author":"JJ Goldberger","year":"2015","unstructured":"Goldberger JJ, Bonow RO, Cuffe M, OBTAIN Investigators et al (2015) Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction. J Am Coll Cardiol 66(13):1431\u20131441","journal-title":"J Am Coll Cardiol"},{"key":"4474_CR50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Steg PG, Tendera M, BEAUTIFU\u2019L Investigators (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo- controlled trial. Lancet 372:807\u2013816","journal-title":"Lancet"},{"key":"4474_CR51","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, SHIFT Investigators et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"4474_CR52","doi-asserted-by":"crossref","first-page":"43F","DOI":"10.1016\/0002-9149(86)90888-X","volume":"57","author":"JK Kjekshus","year":"1986","unstructured":"Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F\u201349F","journal-title":"Am J Cardiol"},{"key":"4474_CR53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1755-5922.2012.00321.x","volume":"31","author":"IBA Menown","year":"2013","unstructured":"Menown IBA, Davies S, Gupta S et\u00a0al (2013) Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand? Cardiovasc Ther 31:215\u2013223","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"4474_CR54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","volume":"371","author":"K Fox","year":"2014","unstructured":"Fox K, Ford I, Steg PG, SIGNIFY Investigators et\u00a0al (2014) Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 371(12):1091\u20131099","journal-title":"N Engl J Med"},{"key":"4474_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsha.2010.12.001","volume":"23","author":"H Abd El Azeem","year":"2011","unstructured":"Abd El Azeem H, Abd El Khalek ES, El Akabawy H (2011) Evaluation of aggressive heart rate reduction in patients with stable angina. J\u00a0Saudi Heart Assoc 23:67\u201373","journal-title":"J Saudi Heart Assoc"},{"key":"4474_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000447443","volume":"135","author":"K Werdan","year":"2016","unstructured":"Werdan K, Perings S, K\u00f6ster R et\u00a0al (2016) Effectiveness of Ivabradine treatment in different subpopulations with stable angina in clinical practice: A pooled analysis of observational studies. Cardiology 135:141\u2013150","journal-title":"Cardiology"},{"issue":"16","key":"4474_CR57","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","volume":"374","author":"JJV McMurray","year":"2016","unstructured":"McMurray JJV, ATMOSPHRE Committee Investigators et\u00a0al (2016) Aliskiren, Enalapril, or Aliskiren and Enalapril in heart failure. N Engl J Med 374(16):1521\u20131532","journal-title":"N Engl J Med"},{"key":"4474_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P et\u00a0al (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed with the special contribution of the Heart Failure association (HFA) of the ESC. Eur Heart J:. doi: 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"11","key":"4474_CR59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, PARADIGM-HF Investigators and Committees et al (2014) Angiotensin-Neprilysin inhibition versus Enalapril in heart failure. N Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"key":"4474_CR60","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M, Borer J, Ford I et\u00a0al (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 102:11\u201322","DOI":"10.1007\/s00392-012-0467-8"},{"issue":"10014","key":"4474_CR61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","volume":"387","author":"G Weisz","year":"2016","unstructured":"Weisz G, G\u00e9n\u00e9reux P, Iniguez A, RIVER-PCI investigators et al (2016) Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 387(10014):136\u2013145","journal-title":"Lancet"},{"issue":"1","key":"4474_CR62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.115.019768","volume":"133","author":"KP Alexander","year":"2016","unstructured":"Alexander KP, Weisz G, Prather K, James S et al (2016) Effects of Ranolazine on angina and quality of life after Percutaneous coronary intervention with incomplete Revascularization \u2013 results from the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) trial. Circulation 133(1):39\u201347","journal-title":"Circulation"},{"key":"4474_CR63","first-page":"57","volume-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand Juli 2010. EI 30:279\u201398. Aktuelle Ausgabe: 22. Februar 2016\/Nr.\u00a07","author":"Robert Koch Institut (RKI)","year":"2010","unstructured":"Robert Koch Institut (RKI) (2010) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand Juli 2010. EI 30:279\u201398. Aktuelle Ausgabe: 22. Februar 2016\/Nr.\u00a07, S 57\u201366"},{"issue":"4","key":"4474_CR64","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cjca.2012.07.010","volume":"29","author":"S Thomas","year":"2013","unstructured":"Thomas S, Gokhale R, Boden WE et al (2013) A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris. Can J Cardiol 29(4):472\u2013482","journal-title":"Can J Cardiol"},{"issue":"2","key":"4474_CR65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","volume":"174","author":"K Stergiopolous","year":"2014","unstructured":"Stergiopolous K, Boden WE, Hartigan P et al (2014) Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial Ischemia: A collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 174(2):232\u2013240","journal-title":"JAMA Intern Med"},{"issue":"4","key":"4474_CR66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archinternmed.2011.1484","volume":"172","author":"K Stergiopolous","year":"2012","unstructured":"Stergiopolous K, Boden WE (2012) Initial coronary stent implantation with medical therapy vs. medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med 172(4):312\u2013319","journal-title":"Arch Intern Med"},{"issue":"4","key":"4474_CR67","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","volume":"5","author":"S Pursnani","year":"2012","unstructured":"Pursnani S, Korley F, Gopaul R et al (2012) Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circ Cardiovasc Interv 5(4):476\u2013490","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"4474_CR68","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.112.131961","volume":"127","author":"S Bangalore","year":"2013","unstructured":"Bangalore S, Pursnani S, Kumar S et\u00a0al (2013) Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stabe ischemic heart disease. Circulation 127(7):789\u2013781","journal-title":"Circulation"},{"issue":"20","key":"4474_CR69","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","volume":"373","author":"SP Sedlis","year":"2015","unstructured":"Sedlis SP, Hartigan PM, Teo KK, Maron DJ, COURAGE Trial Investigators et al (2015) Effects of PCI on long-term survival in patients with stable ischemic heart disease. N Engl J Med 373(20):1937\u20131946","journal-title":"N Engl J Med"},{"issue":"10","key":"4474_CR70","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","volume":"122","author":"W Hueb","year":"2010","unstructured":"Hueb W, Lopes N, Gersh BJ et al (2010) Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 122(10):949\u2013957","journal-title":"Circulation"},{"issue":"2","key":"4474_CR71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjmed.2008.07.027","volume":"122","author":"A Jeremias","year":"2009","unstructured":"Jeremias A, Kaul S, Rosengart TK et\u00a0al (2009) The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 122(2):152\u2013161","journal-title":"Am J Med"},{"key":"4474_CR72","doi-asserted-by":"crossref","unstructured":"Yusuf S, Zucker D, Peduzzi P et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344(8922):563\u2013570","DOI":"10.1016\/S0140-6736(94)91963-1"},{"issue":"17","key":"4474_CR73","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","volume":"364","author":"EJ Velasquez","year":"2011","unstructured":"Velasquez EJ, Lee KL, Deja MA et al (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607\u20131616","journal-title":"N Engl J Med"},{"issue":"16","key":"4474_CR74","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","volume":"374","author":"EJ Velasquez","year":"2016","unstructured":"Velasquez EJ, STICHES Investigators et al (2016) Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med 374(16):1511\u20131520","journal-title":"N Engl J Med"},{"issue":"6","key":"4474_CR75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-152-6-201003160-00007","volume":"152","author":"HC Wijeysundera","year":"2010","unstructured":"Wijeysundera HC, Nallamothu BK, Krumholz HM et al (2010) Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 152(6):370\u2013379","journal-title":"Ann Intern Med"},{"key":"4474_CR76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1745-6215-14-33","volume":"14","author":"Q Li","year":"2013","unstructured":"Li Q, Zhang Z, Yin RX (2013) Drug-eluting stents or coronary artery bypass grafting for nonprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observation studies. Trials 14:33","journal-title":"Trials"},{"issue":"2","key":"4474_CR77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2013.12844","volume":"174","author":"I Sipahi","year":"2014","unstructured":"Sipahi I, Akay MH, Dagdelen S et al (2014) Coronary artery bypss grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med 174(2):223\u2013230","journal-title":"JAMA Intern Med"},{"issue":"15","key":"4474_CR78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK et\u00a0al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15):1503\u20131515","journal-title":"N Engl J Med"},{"key":"4474_CR79","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F et al (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541\u20132619","journal-title":"Eur Heart J"},{"issue":"11","key":"4474_CR80","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne De","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B, FAME 2 Trial Investigators et al (2012) Fractional flow reserve-guided PCI vs. medical therapy in stable coronary disease. N Engl J Med 367(11):991\u20131001","journal-title":"N Engl J Med"},{"issue":"10","key":"4474_CR81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961\u2013972","journal-title":"N Engl J Med"},{"issue":"24","key":"4474_CR82","first-page":"2503","volume":"360","author":"ME Farkouh","year":"2012","unstructured":"Farkouh ME, Domanski M, Sleeper LA et\u00a0al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 360(24):2503\u20132515","journal-title":"N Engl J Med"},{"issue":"24","key":"4474_CR83","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"RL Frye","year":"2009","unstructured":"Frye RL, August P, Brooks MM et\u00a0al (2009) A raondomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360(24):2503\u20132515","journal-title":"N Engl J Med"},{"issue":"5","key":"4474_CR84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","volume":"43","author":"AP Kappetein","year":"2013","unstructured":"Kappetein AP, Head SJ, Morice MC et\u00a0al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5 year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43(5):1006\u20131013","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"4474_CR85","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","volume":"55","author":"A Kapur","year":"2010","unstructured":"Kapur A, Hall RJ, Malik IS et al (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1\u2011year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 55(5):432\u2013440","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"4474_CR86","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMoa1110717","volume":"366","author":"WS Weintraub","year":"2012","unstructured":"Weintraub WS, Grau-Sepulveda MV, Weiss JM et al (2012) Comparative effectiveness of revascularization strategies. N Engl J Med 366(12):1467\u20131476","journal-title":"N Engl J Med"},{"issue":"19","key":"4474_CR87","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.2013.281718","volume":"310","author":"S Deb","year":"2013","unstructured":"Deb S, Wijeysundera HC, Ko DT et\u00a0al (2013) Coronary artery bypass graft surgery vs percutaneous coronary interventions in coronary revacularization: a systematic review. JAMA 310(19):2086\u20132095","journal-title":"JAMA"},{"issue":"4","key":"4474_CR88","doi-asserted-by":"crossref","first-page":"e000354","DOI":"10.1161\/JAHA.113.000354","volume":"2","author":"A Hakeem","year":"2013","unstructured":"Hakeem A, Garg N, Bhatti S et al (2013) Effectiveness of percutaneous coronary intervention with drug \u2013 Eluting stents compared with bypass surgery in diabetics with multivessel coronary disease comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc 2(4):e000354","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4474_CR89","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/icvts\/ivt509","volume":"18","author":"X Li","year":"2014","unstructured":"Li X, Kong M, Jiang D et al (2014) Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis. Interact Cardiovasc Thorac Surg 18(3):347\u2013354","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"4474_CR90","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1055\/s-0029-1245603","volume":"48","author":"W Fischbach","year":"2010","unstructured":"Fischbach W, Darius H, Gross M et al (2010) Gleichzeitige Anwendung von Thrombozytenaggregationshemmern und Protonenpumpeninhibitoren (PPIs). Positionspapier der Deutschen Gesellschaft f\u00fcr Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Kardiologie (DKG). Z Gastroenterol 48:1156\u20131163","journal-title":"Z Gastroenterol"},{"key":"4474_CR91","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","volume":"35","author":"GYH Lip","year":"2014","unstructured":"Lip GYH, Windecker S, Huber K et al (2014) Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HrS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 35:3155\u20133179","journal-title":"Eur Heart J"},{"key":"4474_CR92","volume-title":"Leitlinien- Clearingbericht \u201eKoronare Herzkrankheit\u201c Nieb\u00fcll:videel; (\u00e4zq Schriftenreihe 11)","author":"\u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin (\u00c4ZQ)","year":"2003","unstructured":"\u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin (\u00c4ZQ) (2003) Leitlinien- Clearingbericht \u201eKoronare Herzkrankheit\u201c Nieb\u00fcll:videel; (\u00e4zq Schriftenreihe 11)"},{"issue":"9678","key":"4474_CR93","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, Blackwell L, Collins R et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 373(9678):1849\u20131860","journal-title":"Lancet"},{"issue":"21","key":"4474_CR94","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.282.21.2058","volume":"282","author":"SS Anand","year":"1999","unstructured":"Anand SS, Yusuf S (1999) Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. JAMA 282(21):2058\u20132067","journal-title":"JAMA"},{"issue":"2","key":"4474_CR95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","volume":"167","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Lim W et al (2007) Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 167(2):117\u2013124","journal-title":"Arch Intern Med"},{"issue":"13","key":"4474_CR96","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"M Hurlen","year":"2002","unstructured":"Hurlen M, Abdelnoor M, Smith P et\u00a0al (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347(13):969\u2013974","journal-title":"N Engl J Med"},{"key":"4474_CR97","volume-title":"Arzneiverordnungen. Empfehlungen zur rationalen Pharmakotherapie","author":"Arzneimittelkommission der deutschen \u00c4rzteschaft (Akd\u00c4)","year":"2009","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (Akd\u00c4) (2009) Arzneiverordnungen. Empfehlungen zur rationalen Pharmakotherapie, 22.\u00a0Aufl. MMI, Neu-Isenburg","edition":"22"},{"key":"4474_CR98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9493","key":"4474_CR99","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol- lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267\u20131278","journal-title":"Lancet"},{"issue":"9753","key":"4474_CR100","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 376(9753):1670\u20131681","journal-title":"Lancet"},{"issue":"2","key":"4474_CR101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinthera.2009.02.017","volume":"31","author":"PJ Delahoy","year":"2009","unstructured":"Delahoy PJ, Magliano DJ, Webb K et al (2009) The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. Clin Ther 31(2):236\u2013244","journal-title":"Clin Ther"},{"issue":"11","key":"4474_CR102","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00108-008-2232-7","volume":"49","author":"V Regitz-Zagrosek","year":"2008","unstructured":"Regitz-Zagrosek V, Schubert C, Kruger S (2008) Geschlechterunterschiede in der kardiovaskul\u00e4ren Pharmakotherapie. Internist 49(11):1383\u20131390","journal-title":"Internist"},{"issue":"5","key":"4474_CR103","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.5.5.667","volume":"5","author":"U Thadani","year":"2006","unstructured":"Thadani U, Rodgers T (2006) Side effects of using nitrates to treat angina. Expert Opin Drug Saf 5(5):667\u2013674","journal-title":"Expert Opin Drug Saf"},{"issue":"9867","key":"4474_CR104","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","volume":"381","author":"V Farooq","year":"2013","unstructured":"Farooq V, van Klaveren D, Steyerberg ES et\u00a0al (2013) Anatomical and clinical characterisitics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381(9867):639\u2013650","journal-title":"Lancet"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-016-4474-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:55:51Z","timestamp":1498326951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-016-4474-9"}},"subtitle":["Was ist neu, was ist besonders wichtig?"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1007\/s00059-016-4474-9","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}